ALIOS |
American Lifestyle Induced Obesity Syndrome |
ALMS1 |
Alström |
ALR |
Augmenter of liver regeneration |
APOE2ki |
Apolipoprotein E2 knock-in |
CCl4
|
Carbon tetrachloride |
CD |
Diet deficient for/low in choline |
CDAA |
Choline-deficient L-amino acid-defined diet |
DIAMOND |
Diet-induced animal model of non-alcoholic fatty liver disease |
FLS |
Fatty liver Shionogi |
FXR |
Farnesoid X receptor |
Gank |
Gankyrin |
GFER |
Growth Factor ERV1 homolog of Saccharomyces cerevisiae
|
HCC |
Hepatocellular carcinoma |
HFC |
High-fat/high-cholesterol diet |
HFD |
High-fat diet |
Ldlr |
Low-density lipoprotein receptor |
MAT1a |
methionine adenosyltransferase 1A |
MC4R |
Melanocortin 4 receptor |
MetS |
Metabolic Syndrome |
MS-NASH |
Mice formerly known as FATZO/Pco |
NAFLD |
Non-alcoholic fatty liver disease |
NASH |
Non-alcoholic steatohepatitis |
NEMO |
NF-κB essential modulator |
PNPLA3 |
Patatin-like phospholipase domain-containing 3 |
PPAR |
Peroxisome proliferator-activated receptor |
PTEN |
Phosphatase and tensin homolog |
T2D |
Type 2 Diabetes |
TAA |
Thioacetamide |
TM6SF2 |
Transmembrane 6 superfamily member 2 |
TNFα |
Tumor necrosis factor α |
TSOD |
Tsumura-Suzuki Obese Diabetes |